Glatiramer Acetate 40 Mg/Ml Three Times A Week for The Treatment of Relapsing Forms of Multiple Sclerosis: Potential Cost Benefits of A Regimen With Infrequent Injections Which May Minimise Switching to The Newly-Introduced First-Line and Second-Line Dise
Garcia Bujalance L, Kelly M, Blackney M, Zeidman R, Skroumpelos A, Bijedic A, Sánchez-de la Rosa R, Plich A
Value Health. 2015 Nov; 18(7):A751. Epub 2015 Oct 20. PMID: 26534208.Abstract